Parallax Volatility Advisers L.P. bought a new stake in Healthcare AI Acquisition Corp. (NASDAQ:HAIA – Get Rating) during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 122,629 shares of the company's stock, valued at approximately $1,237,000. Parallax Volatility Advisers L.P. owned approximately 0.45% of Healthcare AI Acquisition as of its most recent filing with the SEC.

Several other large investors have also made changes to their positions in the company. Polar Asset Management Partners Inc. bought a new position in Healthcare AI Acquisition in the 3rd quarter valued at $1,801,000. Cantor Fitzgerald L. P. raised its holdings in shares of Healthcare AI Acquisition by 161.1% in the third quarter. Cantor Fitzgerald L. P. now owns 1,044,549 shares of the company's stock valued at $10,534,000 after buying an additional 644,549 shares during the last quarter. Verition Fund Management LLC acquired a new position in Healthcare AI Acquisition during the 2nd quarter worth about $2,232,000. Aristeia Capital LLC grew its holdings in Healthcare AI Acquisition by 44.3% during the 2nd quarter. Aristeia Capital LLC now owns 721,378 shares of the company's stock worth $7,156,000 after acquiring an additional 221,378 shares during the last quarter. Finally, Woodline Partners LP increased its position in Healthcare AI Acquisition by 100.0% in the 2nd quarter. Woodline Partners LP now owns 300,000 shares of the company's stock valued at $2,976,000 after acquiring an additional 150,000 shares in the last quarter. Institutional investors own 66.55% of the company's stock.

Healthcare AI Acquisition Stock Down 0.1 %

Shares of NASDAQ HAIA opened at $10.40 on Friday. Healthcare AI Acquisition Corp. has a 1-year low of $9.87 and a 1-year high of $10.85. The company has a 50-day moving average of $10.34 and a two-hundred day moving average of $10.20.

Healthcare AI Acquisition Profile

(Get Rating)

Healthcare AI Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends on healthcare and pharmaceutical companies in the e-clinical, healthcare information technology, or outsourced pharmaceutical services industries.

Read More

• Get a free copy of the StockNews.com research report on Healthcare AI Acquisition (HAIA)
• What the SVB Financial Collapse Means for U.S. Banks
• MarketBeat Week in Review – 3/6 – 3/10
• 2 Offshore Drilling Stocks Set to Extract Big Profits
• Three Staples Stocks With Double-Digit Upside Ahead
• Can Investors Trust Consumers to Lift American Outdoor Brands?

Receive News & Ratings for Healthcare AI Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare AI Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.